Sponsor pipeline

Medical College of Wisconsin clinical trial pipeline

Get alerts when Medical College of Wisconsin's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

15 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 9 with minor changes only.

  1. Notable

    MAPPER · Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment · Hormone Receptor-Positive HER2-negative Breast Cancer

    Enrollment increased: 100 → 185 participants

    Also in this update: Primary completion moved earlier from Dec 2028 to Sep 2028; Study completion moved earlier from Dec 2029 to Dec 2028

    Medical College of WisconsinPhase 2 NCT06361940 Registry history of NCT06361940 on ClinicalTrials.gov (opens the registry)

Show 9 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-19 NCT07881692 GOT VOICE GROUP SINGING Not Yet Recruiting

Active trials by phase

Early Phase 1
5
Phase 1
12
Phase 1/2
4
Phase 2
35
Phase 3
2
Phase 4
4
Not charted: 98 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 45

Get alerts when Medical College of Wisconsin's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free